Pelitinib-d6 structure
|
Common Name | Pelitinib-d6 | ||
---|---|---|---|---|
CAS Number | 1325223-34-4 | Molecular Weight | 473.96 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C24H17D6ClFN5O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Pelitinib-d6Pelitinib-d6 (EKB-569-d6) is the deuterium labeled Pelitinib. Pelitinib (EKB-569) is an irreversible inhibitor of EGFR with an IC50 of 38.5 nM; also slightly inhibits Src, MEK/ERK and ErbB2 with IC50s of 282, 800, and 1255 nM, respectively[1][2]. |
Name | Pelitinib-d6 |
---|
Description | Pelitinib-d6 (EKB-569-d6) is the deuterium labeled Pelitinib. Pelitinib (EKB-569) is an irreversible inhibitor of EGFR with an IC50 of 38.5 nM; also slightly inhibits Src, MEK/ERK and ErbB2 with IC50s of 282, 800, and 1255 nM, respectively[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C24H17D6ClFN5O2 |
---|---|
Molecular Weight | 473.96 |